Protective effect of flavonoids from Passiflora edulis Sims on diabetic complications in rats

J Pharm Pharmacol. 2021 Sep 7;73(10):1361-1368. doi: 10.1093/jpp/rgab046.

Abstract

Objectives: This study was carried out to evaluate the effects of flavonoids present in leaves of Passiflora edulis fruit on complications induced by diabetes in rats.

Methods: The extract of P. edulis leaf was obtained by 70% ethanol maceration. From the dry extract, the fractions were obtained by consecutive liquid-liquid partition with hexane, ethyl acetate and n-butanol. The content of isoorientin of ethyl acetate and n-butanol fractions was determined by ultra-performance liquid chromatography coupled with electrospray and triple quadrupole ionization (TQD) analysis in tandem mass spectrometry (UPLC-ESI-Tq-MS). Only Fr-BuOH was used to treat diabetic or not Wistar rats. Biochemical parameters, platelet aggregation and production of reactive species were evaluated.

Key findings: The UPLC-ESI-Tq-MS analysis revealed the presence of several flavonoids, among which we identified five possible flavonoids c-heterosides (luteolin-7-O-pyranosyl-3-O-glucoside, apigenin-6-8-di-C-glycoside, apigenin-6-C-arabinoside-8-C-glycoside, isoorientin, isovitexin). The diabetic rats (treated intraperitoneally with alloxan, 150 mg/kg) treated with Fr-BuOH (20 mg/kg/day for 90 days) presented improvement in blood glucose, serum levels of fructosamine, lipid profile and urea. Furthermore, the Fr-BuOH reduced both platelet aggregation and the production of oxidant species in diabetic animals.

Conclusions: These results suggested that flavonoid C-glycosides present in the Fr-BuOH may be beneficial for the diabetic state, preventing complications induced by diabetes.

Keywords: Passiflora edulis; LC-MS quantification; antiplatelet; diabetes; isoorientin.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Apigenin / analysis
  • Apigenin / pharmacology
  • Apigenin / therapeutic use
  • Blood Glucose / metabolism
  • Chromatography, High Pressure Liquid
  • Diabetes Complications / blood
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / drug therapy*
  • Flavones / analysis
  • Flavones / pharmacology
  • Flavones / therapeutic use
  • Flavonoids / analysis
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use*
  • Fructosamine / blood
  • Glucosides / analysis
  • Glucosides / pharmacology
  • Glucosides / therapeutic use
  • Glycosides / analysis
  • Glycosides / pharmacology
  • Glycosides / therapeutic use*
  • Luteolin / analysis
  • Luteolin / pharmacology
  • Luteolin / therapeutic use
  • Male
  • Passiflora / chemistry*
  • Phytotherapy*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Plant Leaves / chemistry
  • Platelet Aggregation / drug effects
  • Rats
  • Rats, Wistar
  • Tandem Mass Spectrometry

Substances

  • Antioxidants
  • Blood Glucose
  • Flavones
  • Flavonoids
  • Glucosides
  • Glycosides
  • Plant Extracts
  • violarvensin
  • Fructosamine
  • Apigenin
  • luteolin-7-glucoside
  • homoorientin
  • isovitexin
  • Luteolin